Relay Therapeutics's market cap is currently $684.60M. The company's EPS TTM is $-2.613; its P/E ratio is ―; Relay Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 25.55M	$ 1.38M	$ 3.03M	$ 82.65M	$ 0.00
Gross Profit	$ 20.28M	$ -2.75M	$ -896.00K	$ 79.11M	$ -2.85M
Operating Income	$ -373.00M	$ -299.27M	$ -364.70M	$ -55.80M	$ -84.05M
EBITDA	$ -374.15M	$ -306.82M	$ -222.18M	$ -52.25M	$ -81.20M
Net Income	$ -341.97M	$ -254.26M	$ -496.81M	$ -49.01M	$ -66.50M
Balance Sheet
Cash & Short-Term Investments	$ 750.09M	$ 998.92M	$ 958.07M	$ 678.06M	$ 355.82M
Total Assets	$ 843.98M	$ 1.10B	$ 1.01B	$ 799.83M	$ 393.07M
Total Debt	$ 53.47M	$ 57.74M	$ 22.90M	$ 24.42M	$ 24.83M
Net Debt	$ -90.27M	$ -941.17M	$ -935.17M	$ -423.22M	$ -17.12M
Total Liabilities	$ 91.98M	$ 149.55M	$ 110.64M	$ 36.54M	$ 573.51M
Stockholders' Equity	$ 752.00M	$ 950.22M	$ 897.81M	$ 763.29M	$ -180.44M
Cash Flow
Free Cash Flow	$ -304.44M	$ -238.55M	$ -77.88M	$ -104.42M	$ -74.14M
Operating Cash Flow	$ -300.32M	$ -229.49M	$ -74.41M	$ -102.49M	$ -66.13M
Investing Cash Flow	$ 257.63M	$ -188.75M	$ -479.51M	$ 81.67M	$ -319.02M
Financing Cash Flow	$ 34.75M	$ 289.91M	$ 388.09M	$ 426.51M	$ 5.61M

Currency in USD

Relay Therapeutics Earnings and Revenue History

Income Statement >

Relay Therapeutics Debt to Assets

Balance Sheet >

Relay Therapeutics Cash Flow

Cash Flow >

Relay Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing